Propofol Reduces Inflammation Caused by Bacterial Endotoxin
Author Information
Author(s): Hsing Chung-Hsi, Lin Ming-Chung, Choi Pui-Ching, Huang Wei-Ching, Kai Jui-In, Tsai Cheng-Chieh, Cheng Yi-Lin, Hsieh Chia-Yuan, Wang Chi-Yun, Chang Yu-Ping, Chen Yu-Hong, Chen Chia-Ling, Lin Chiou-Feng
Primary Institution: National Cheng Kung University, Tainan, Taiwan
Hypothesis
Does propofol inhibit LPS-induced inflammatory activation in macrophages?
Conclusion
Propofol reduces LPS-induced inflammatory responses in macrophages by inhibiting the interconnected ROS/Akt/IKKβ/NF-κB signaling pathways.
Supporting Evidence
- Propofol significantly reduced LPS-induced iNOS and NO production.
- Propofol inhibited the production of pro-inflammatory cytokines TNF-α, IL-6, and IL-10.
- Propofol treatment reduced LPS-induced phosphorylation of IKKβ and NF-κB.
- Propofol decreased ROS generation in macrophages.
Takeaway
Propofol, a common anesthetic, helps reduce inflammation caused by bacteria in immune cells, making it useful in treating infections.
Methodology
The study used in vitro and in vivo experiments to assess the effects of propofol on LPS-induced inflammation in macrophages.
Potential Biases
Potential bias in the interpretation of results due to the controlled experimental conditions.
Limitations
The study may not fully represent clinical scenarios due to differences in animal models and dosages used.
Participant Demographics
Male C57BL/6 mice were used for in vivo studies.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website